首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cancer And Metastasis Reviews

Cancer And Metastasis Reviews杂志,由Springer US出版,于1982年创刊,Quarterly,出版语言English,ISSN:0167-7659,E-ISSN:1573-7233。

投稿咨询
Cancer And Metastasis Reviews
Cancer And Metastasis Reviews
Cancer And Metastasis Reviews
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
12.7
CiteScore
16.3
期刊收录
SCI、SCIE

Cancer And Metastasis Reviews(中文译名:《癌症和转移评论》),ISSN:0167-7659,EISSN:1573-7233,是Springer US出版的国际性学术期刊,创刊于1982年,以Quarterly形式稳定发行,2026年总发文量约73篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达12.7,2025年期刊CiteScore为16.3,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Cancer And Metastasis Reviews长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAGERMANY (FED REP GER)、CHINA MAINLAND、Hungary、Italy、England、India等为核心发文国家与地区;UNIVERSITY OF TEXAS SYSTEMWAYNE STATE UNIVERSITY、SEMMELWEIS UNIVERSITY、BARBARA ANN KARMANOS CANCER INSTITUTE、UNIVERSITY OF CALIFORNIA SYSTEM、HELMHOLTZ ASSOCIATION、HUNGARIAN ACADEMY OF SCIENCES等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 26 / 333

92.3

学科:ONCOLOGY SCIE Q1 55 / 333

83.63

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 34 / 328

89.8

学科:ONCOLOGY SCIE Q1 60 / 328

81.86


中国学者近期发文

1
Pexidartinib: Current advances in the symptomatic treatment of tenosynovial giant cell tumor

Author:Yuan, Yulin; Zhang, Zhuoer; Jiang, Yanfeng; Ye, Ting; Chen, Jing

Journal: CANCER AND METASTASIS REVIEWS. 2026; Vol. 45, Issue 2, pp. -. DOI: 10.1007/s10555-026-10328-z

2
Neuro-tumor interactions in peripheral tumor

Author:Ma, Xueshiyu; Ji, Peixuan; Zheng, Jiahao; Cai, Shuqi; Xu, Kan; Sun, Yongwei; Liu, Dejun

Journal: CANCER AND METASTASIS REVIEWS. 2026; Vol. 45, Issue 2, pp. -. DOI: 10.1007/s10555-026-10321-6

3
Dissecting the aberrant vasculature of glioblastoma: mechanisms and therapeutic target

Author:Li, Yinan; Du, Yinfei; Guan, Fan; Li, Xuetong; Cui, Shu; Gao, Wei; Long, Xinmiao; Wu, Minghua

Journal: CANCER AND METASTASIS REVIEWS. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1007/s10555-026-10319-0

4
Patient-derived complex organoids are a critical tool to understand and explore pediatric malignant brain tumor

Author:Deschuyter, Marlene; Martin, Sophie; Salmanli, Chinar; Hubsch, Clemence; Vincent, Audrey; Meignan, Samuel; Furlan, Alessandro; Cosset, Erika; Burckel, Helene; Noel, Georges; Salzet, Michel; Duhamel, Marie; Raffo-Romero, Antonella; Boura, Cedric; Pinel, Sophie; Coca, Andres; Joud, Antony; Karnoub, Melodie Anne; Chastagner, Pascal; Raimbault, Sandra; Sudour-Bonnange, Helene; Flacher, Vincent; Bernhard, Chloe; Entz-Werle, Natacha

Journal: CANCER AND METASTASIS REVIEWS. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1007/s10555-026-10316-3

5
Prospects and limitations of NK cell adoptive therapy in clinical application

Author:Deng, Yamin; Wu, Chen; Na, Jintong; Tang, Jing; Qin, Simin; Zhang, Zhiyong; Zhong, Liping

Journal: CANCER AND METASTASIS REVIEWS. 2025; Vol. 44, Issue 3, pp. -. DOI: 10.1007/s10555-025-10273-3

6
Metal-modulated T cell antitumor immunity and emerging metalloimmunotherap

Author:Liao, Peiyun; Zhou, Ying; Qiu, Yingqi; Hu, Rong; Li, Hongyan; Sun, Hongzhe; Li, Yuhua

Journal: CANCER AND METASTASIS REVIEWS. 2025; Vol. 44, Issue 2, pp. -. DOI: 10.1007/s10555-025-10266-2

7
Lactate metabolism and lactylation in breast cancer: mechanisms and implication

Author:Qiao, Yifan; Liu, Yijia; Ran, Ran; Zhou, Yan; Gong, Jin; Liu, Lijuan; Zhang, Yusi; Wang, Hui; Fan, Yuan; Fan, Yihan; Nan, Gengrui; Zhang, Peng; Yang, Jin

Journal: CANCER AND METASTASIS REVIEWS. 2025; Vol. 44, Issue 2, pp. -. DOI: 10.1007/s10555-025-10264-4

8
p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repai

Author:Yang, Xiaojuan; Cao, Xunjie; Zhu, Qing

Journal: CANCER AND METASTASIS REVIEWS. 2025; Vol. 44, Issue 1, pp. -. DOI: 10.1007/s10555-025-10250-w

9
Mitochondrial alterations and signatures in hepatocellular carcinom

Author:Chen, Tsung-Hsien; Lin, Shu-Hsien; Lee, Ming-Yang; Wang, Hsiang-Chen; Tsai, Kun-Feng; Chou, Chu-Kuang

Journal: CANCER AND METASTASIS REVIEWS. 2025; Vol. 44, Issue 1, pp. -. DOI: 10.1007/s10555-025-10251-9

10
RETRACTION: EET signaling in cance

Author:Panigrahy, Dipak; Greene, Emily R.; Pozzi, Ambra; Wang, Dao Wen; Zeldin, Darryl C.

Journal: CANCER AND METASTASIS REVIEWS. 2025; Vol. 44, Issue 1, pp. -. DOI: 10.1007/s10555-024-10229-z


在线咨询

Cancer And Metastasis Reviews

国际简称:CANCER METAST REV参考译名:癌症和转移评论

年发文量:73 CiteScore:16.3 是否预警:否 Gold OA文章占比:52.11% 研究类文章占比:0.00%

杂志社联系方式:SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ

Cancer And Metastasis Reviews